Occult hepatitis C virus infection among hemodialysis patients

Journal of the American Society of Nephrology

Volumn 19, Issue 12, 2008, Pages 2288-2292

  Barril, Guillermina ^a   Castillo, Inmaculada ^b   Arenas, María Dolores ^g   Espinosa, Mario ^h   Garcia Valdecasas, Juan ⁱ   Garcia Fernández, Nuria ^j   González Parra, Emilio ^c   Alcazar, José María ^d   Sánchez, Carmen ^e   Diez Baylón, José Carlos ^k   Martinez, Pilar ^f   Bartolomé, Javier ^b   Carreño, Vicente ^b,l  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Fundación para el Estudio de Las Hepatitis Virales

^c HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f ICN FMC El Pilar   (Spain)

^g Clinica Perpetuo Socorro   (Spain)

^h HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^j UNIVERSITY CLINIC OF NAVARRA   (Spain)

^k Dialysis Center FRIAT   (Spain)

^l Fundacion para el Estudio de Las Hepatitis Virales   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GENOMIC RNA; LIVER ENZYME; VIRUS RNA;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONFIDENCE INTERVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LOGISTIC REGRESSION ANALYSIS; MORTALITY; NUCLEOTIDE SEQUENCE; OCCULT HEPATITIS C VIRUS INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 57149087313     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008030293     Document Type: Article

References (18)

1. Miller RH, Purcell RH: Hepatitis C virus shares amine acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A 87: 2057-2061, 1990
2. Clarke B: Molecular virology of hepatitis C virus. J Gen Virol 78: 2397-2410, 1997
3. Fabrizi F, Lunghi G, Ganeshan SV, Martin P, Messa P: Hepatitis C virus infection and the dialysis patient. Semin Dial 20: 416-422, 2007
4. Barril G, Traver JA: Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: Effect of time, initiating HCV prevalence studies and adoption of isolation measures. Antiviral Res 60: 129-134, 2003
5. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50: 1-43, 2001
6. Barril G, González Parra E, Alcázar R, Arenas D, Campistol JM, Caramelo C, Carrasco M, Carreño V, Espinosa M, García Valdecasas J, Górriz JL, López MD, Martín L, Ruiz P, Terruel JL, Spanish Society of Nephrology: Guidelines on hemodialysis-associated viral infections. Nefrologia 24[Suppl 2]: 43-66, 2004
7. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P: High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 54: 151-156, 2000
8. Lopes EP, Gouveia EC, Albuquerque AC, Sette LH, Mello LA, Moreira RC, Coelho MR: Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis to identify biochemical activity in patients with hepatitis C viremia. J Clin Virol 35: 298-302, 2006
9. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y: Hypoaminotransferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal. Gastroenterology 109: 1295-1300, 1995
10. Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodríguez-Iñigo E, de Lucas S, Salas C, Jiménez-Heffernan JA, Pérez-Mota A, Graus J, López-Alcorocho JM, Carreño V: Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189: 7-14, 2004
11. Schneeberger PM, Keur I, van Loon AM, Mortier D, de Coul KO, van Haperen AV, Sanna R, van Der Heijden TG, van Den Hoven H, van Hamersvelt HW, Quint W, van Doorn LJ: The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: A nationwide prospective study. J Infect Dis 182: 1291-1299, 2000
12. Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Bartolomé J, Carreño V: Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis 43: 1277-1283, 2006
13. Bartolomé J, López-Alcorocho, Castillo I, Rodríguez-Iñigo E, Quiroga JA, Palacios R, Carreño V: Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 81: 7710-7715, 2007
14. Bullock GC, Bruns DE, Haverstick DM: Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes. Clin Chem 48: 2147-2154, 2002
15. Kwok S, Higuchi R: Avoiding false positive with PCR. Nature 339: 237-238, 1989
16. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The ClustalX windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 24: 4876-4882, 1997
17. Kumar S, Tamura K, Jakobsen IB, Nei M: MEGA2: Molecular evolutionary genetics analysis software. Bioinformatics 17: 1244-1245, 2001
18. Castillo I, Rodríguez-Iñigo E, Bartolomé J, de Lucas S, Ortíz-Movilla N, López-Alcorocho JM, Pardo M, Carreño V: Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult HCV infection. Gut 54: 682-685, 2005